Zymergen IPO buyers have until Oct. 11 to claim from a $125 million securities settlement, with a final approval hearing set for Oct. 13 in San Jose

Image Credit: Murat Kizaibek - CC BY-SA 4.0/Wiki Commons

People who bought shares in Zymergen’s April 2021 initial public offering have until October 11, 2026 to submit a Proof of Claim to a $125 million securities class action settlement. A federal judge in San Jose will hold the final approval hearing two days later, on October 13 at 10:00 a.m.

The settlement website says the fund is $125 million in cash, to be distributed after taxes. The case is Wang v. Zymergen, No. 5:21-cv-06028-PCP, before U.S. District Judge P. Casey Pitts in the Northern District of California.

Which purchases are covered

The class is limited to purchases made through the IPO itself. According to the settlement’s frequently asked questions, it covers shares bought pursuant to or traceable to the registration statement and prospectus issued in connection with Zymergen’s April 2021 initial public offering. Shares bought months later on the open market, with no link to that offering, are a different matter.

That wording is where most former holders will stop and check their own records: whether the shares came in at the offering or shortly afterward, which account bought them, and whether the purchase can be tied to the April 2021 prospectus. Anyone who bought, or who was allocated shares through a broker in the offering, has the clearest case. Anyone who is unsure should read the notice’s definition of the class before filing.

The notice also sets a floor. Under the settlement, there are no distributions to claimants who would receive less than $10.

For people working through which purchase dates count and what to attach, The Settlement & Refund Recovery System includes the four-date rule for reading a settlement notice and a step-by-step filing walkthrough.

Walk through the Zymergen proof of claim and its Oct. 11 date →

Who is paying, and why Zymergen is not

Zymergen, the synthetic biology company that went public in 2021, filed for Chapter 11 bankruptcy in October 2023 and is not a party to the settlement, according to the tracker Open Class Actions. The money instead comes from other defendants: former officers and directors, the underwriters of the offering and venture capital funds. The same account lists the underwriters as J.P. Morgan, Goldman Sachs, Cowen, Bank of America, UBS and Lazard.

That list comes from the tracker, not from the settlement site, and the court’s own papers are the better place to confirm who contributed. The court documents page posts the settlement stipulation, the order granting preliminary approval, the motion for final approval and the fee motion.

What a payment may look like

Open Class Actions puts the estimate at about $6.21 per share before court-approved fees, with fees of roughly $2.01 per share in that calculation. It is an estimate, and the final figure depends on how many valid claims come in and on what the judge approves at the October 13 hearing. Claimants who held fewer shares, or who sold at higher prices, will see a different result than the headline per-share number.

A hearing does not end the process. After a judge grants final approval, payments usually follow only once any appeals are resolved and the administrator finishes processing claims, so a check does not come immediately after October 13.

Where the hearing takes place

The final approval hearing is set for October 13, 2026 at 10:00 a.m. at the Robert F. Peckham Federal Building in San Jose. A claim does not depend on showing up. It depends on the Proof of Claim being submitted by October 11.

Pulling trade records and filing by October 11

With only a few days left, the quickest free route is the settlement website. The notice and claim form page carries the Notice of Proposed Settlement of Class Action, the Summary Notice and the Proof of Claim.

The claim form asks for trade details, so the first job is to find them: brokerage statements from April 2021 and the months after, trade confirmations showing the IPO purchase, and records of any sales. People who bought through a retirement account should ask the custodian for the statements covering it. If paper records are gone, the broker can often supply an older statement, but that takes days, which is time the October 11 date does not leave in large supply.

Keep a copy of the submission confirmation and the date it was filed, along with the case name and number, Wang v. Zymergen, No. 5:21-cv-06028-PCP, in case a question comes up later. The settlement site is the place to look for news after the hearing about payment timing.

The Settlement & Refund Recovery System pairs a claim log and payment tracker with the scam-proof rules, so each filing, date and confirmation sits in one place and unexpected fee requests are easier to spot.

Get the filing walkthrough for the Zymergen settlement →

This article was produced with AI assistance and reviewed by The Financial Wire’s editorial team.

Leave a Reply

Your email address will not be published. Required fields are marked *